You are here: Home :: Area NEM :: Medical science :: Human medicine

Andrea Mosca, Renata Paleari, Ferruccio Ceriotti, Annunziata Lapolla, Domenico Fedele

Biological Variability of Albumin Excretion Rate and Albumin-to-Creatinine Ratio in Hypertensive Type 2 Diabetic Patients

The importance of measuring microalbuminuria is well established. However, only scanty data are available concerning the biological variability of albumin excretion in type 2 diabetic subjects. We report our experience from a large clinical trial of a new antihypertensive drug (Lercanidipine) designed to reduce albumin excretion and blood pressure in type 2 diabetic patients with hypertension and microalbuminuria.

Eighty seven patients with persistent microalbuminuria were studied within 1 year of the clinical trial. The measurements were performed on blood and timed urine samples frozen at ?80 °C and shipped to a central laboratory unit. Preliminary experiments were performed to assess albumin stability in urine under various conditions (4 °C, ?20 °C and ?80 °C), particularly with regard to the albumin/creatinine ratio. Urine samples can be stored up to 3 weeks at 4 °C or up to 2 months at ?80 °C. The biological variability of the albumin excretion rate was 25.7%, while that of the albumin/creatinine ratio was 13.4%. These data are useful in defining the analytical goals of imprecision for microalbuminuria (CV = 13% for albumin, and CV = 6% for albumin/creatinine ratio). No correlation between albumin/creatinine ratio and HbA_1c was found in the cohort of 61 microalbuminuric patients who completed the trial.

The results of this study confirm that the albumin/creatinine ratio is much more suitable for monitoring albumin excretion in longitudinal studies than the albumin excretion rate.

Clinical Chemical Laboratory Medicine, Walter de Gruyter

Print ISSN: 1434-6621
Volume: 41, 09/2003
Pages: 1229 - 1233

Show full article (external site)

Show all available items of this journal

 

Area NEM